What to expect as FDA advisory panel debates Pfizer COVID booster shots

US 17-9-2021 ABC News: U.S. 32

The FDA's independent advisory committee will review data submitted by Pfizer and discuss whether a booster dose is safe for widespread use on Friday. 
Read The Rest at ABC News: U.S.- (opens a new tab)